Reports: Cell therapy

3 items Clear filters

1. Published9 Nov 2026

   Conference

   ASH 2026: hematology readouts

   55 selected hematology readouts, with highlights, efficacy and safety charts, patient settings and original sources. Abstract-release preview.

   • Hematology
   • Cell therapy
   • Bispecific antibody
   • ASH
2. Data as of4 Oct 2026

   Worked example

   Phase 1 trials of B7-H3-targeted drugs

   Every Phase 1 and Phase 1/2 trial of a B7-H3-directed drug, with modality, tumour type, geography and status.

   • Oncology
   • ADC
   • Cell therapy
   • B7-H3
3. Undated

   Landscape

   Claudin 18.2 research landscape

   Source-linked programs, patient populations, clinical results and rights across antibodies, ADCs and cell therapies.

   • Oncology
   • Antibody
   • ADC
   • Cell therapy
   • Claudin 18.2